NLRP3 and infection: In addition, Yalcinkaya et al. (2021) showed that the SARS-CoV-2 envelope (E) protein can suppress NLRP3 inflammasome priming at early stages of infection, minimizing the levels of pro-inflammatory cytokines [79].